Literature DB >> 1313102

Assessment of the relative cytotoxicity of Porphyromonas gingivalis cells, products, and components on human epithelial cell lines.

H N Shah1, S E Gharbia, C M O'Toole.   

Abstract

Established human cell lines derived from a transitional cell carcinoma (J82), a squamous carcinoma (SCaBER), and a normal urothelium (HCV-29) were used to assess the relative cytotoxicity and tissue specificity of putative virulence determinants of P. gingivalis W83. Intact cells of W83 had no effect on any of the cell lines, whereas disrupted cells caused extensive cytotoxicity particularly to monolayers of HCV-29 and J82. The purified cysteine proteinase, gingivain, caused marked disruption of the basement membrane of the SCaBER monolayers but had no cytotoxic effects. Use of the thiol-inhibitor, 2,2'-dipyridyl disulphide revealed that the effects observed with the vesicles and the culture supernatant were due to the presence of the cysteine proteinase. The attachment of vesicles to the SCaBER cells was evident in electron micrographs. Short-chain volatile fatty acids added in concentrations equivalent to those present in the culture supernatant had no effect on any of the cell lines tested. Culture supernatants obtained from high speed centrifugation (150,000 x g) showed no cytotoxic effects. This was in marked contrast to the supernatant obtained by lower sedimentation (18,000 x g), which damaged all monolayers tested. These results suggest that these cell lines are potentially useful for assessing putative virulence determinants of P. gingivalis and other periodontal pathogens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313102     DOI: 10.1902/jop.1992.63.1.44

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  8 in total

1.  Gingipains from Porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells.

Authors:  Shaun M Sheets; Jan Potempa; James Travis; Carlos A Casiano; Hansel M Fletcher
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Effect of Porphyromonas gingivalis on epithelial cell MMP-9 type IV collagenase production.

Authors:  P Fravalo; C Ménard; M Bonnaure-Mallet
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  Lipopolysaccharide from the periodontal pathogen Porphyromonas gingivalis prevents apoptosis of HL60-derived neutrophils in vitro.

Authors:  D A Murray; J M A Wilton
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 4.  Gingipain-dependent interactions with the host are important for survival of Porphyromonas gingivalis.

Authors:  Shaun M Sheets; Antonette G Robles-Price; Rachelle M E McKenzie; Carlos A Casiano; Hansel M Fletcher
Journal:  Front Biosci       Date:  2008-05-01

5.  Anti-inflammatory and analgesic activity of the bradykinin antagonist, icatibant (Hoe 140), against an extract from Porphyromonas gingivalis.

Authors:  T Griesbacher; R L Sutliff; F Lembeck
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

6.  Identification of interspecies interactions affecting Porphyromonas gingivalis virulence phenotypes.

Authors:  Elizabeth L Tenorio; Brian A Klein; Wai S Cheung; Linden T Hu
Journal:  J Oral Microbiol       Date:  2011-10-17       Impact factor: 5.474

7.  Temporal activation of anti- and pro-apoptotic factors in human gingival fibroblasts infected with the periodontal pathogen, Porphyromonas gingivalis: potential role of bacterial proteases in host signalling.

Authors:  Sonya Urnowey; Toshihiro Ansai; Vira Bitko; Koji Nakayama; Tadamichi Takehara; Sailen Barik
Journal:  BMC Microbiol       Date:  2006-03-08       Impact factor: 3.605

8.  Effects of Short-Chain Fatty Acids on Human Oral Epithelial Cells and the Potential Impact on Periodontal Disease: A Systematic Review of In Vitro Studies.

Authors:  Gabriel Leonardo Magrin; Franz Josef Strauss; Cesar Augusto Magalhães Benfatti; Lucianne Cople Maia; Reinhard Gruber
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.